Published in Clin Exp Rheumatol on July 09, 2002
Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis. Ann Rheum Dis (2004) 0.91
Sustained β-catenin activity in dermal fibroblasts promotes fibrosis by up-regulating expression of extracellular matrix protein-coding genes. J Pathol (2015) 0.87
Differential global and extra-cellular matrix focused gene expression patterns between normal and glaucomatous human lamina cribrosa cells. Mol Vis (2009) 0.86
Versican is upregulated in circulating monocytes in patients with systemic sclerosis and amplifies a CCL2-mediated pathogenic loop. Arthritis Res Ther (2013) 0.81
High frequency ultrasound of skin involvement in systemic sclerosis - a follow-up study. Arthritis Res Ther (2015) 0.77
Docetaxel-Induced Systemic Sclerosis with Internal Organ Involvement Masquerading as Congestive Heart Failure. Case Reports Immunol (2017) 0.75
ABSORPTION SPECTRUM OF FURTHER PURIFIED CYTOCHROME C. Science (1939) 27.02
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Reduced tuberculosis case notification associated with scaling up antiretroviral treatment in rural Malawi. Int J Tuberc Lung Dis (2011) 2.13
Intestinal absorption of dietary cadmium in women depends on body iron stores and fiber intake. Environ Health Perspect (1994) 1.88
Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Arthritis Rheum (1994) 1.83
Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord blood. Environ Res (2000) 1.74
Creatinine versus specific gravity-adjusted urinary cadmium concentrations. Biomarkers (2005) 1.66
Human cervical ripening, an inflammatory process mediated by cytokines. Mol Hum Reprod (2000) 1.40
Toxic and essential elements in placentas of Swedish women. Clin Biochem (2000) 1.39
Metals and women's health. Environ Res (2002) 1.33
Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol (1990) 1.20
Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1beta and tumor necrosis factor-alpha. J Cell Biochem (2000) 1.17
Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis (1998) 1.12
HIV care need not hamper maternity care: a descriptive analysis of integration of services in rural Malawi. BJOG (2012) 1.10
Metal-bone interactions. Toxicol Lett (2000) 1.09
Bioavailability of cadmium from shellfish and mixed diet in women. Toxicol Appl Pharmacol (1996) 1.08
Liver function in some common rheumatic disorders. Scand J Rheumatol (1980) 1.08
The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) (2003) 1.04
Circulating collagen metabolites in systemic sclerosis. Differences between limited and diffuse form and relationship with pulmonary involvement. Rheumatology (Oxford) (2000) 1.04
Dietary cadmium exposure and prostate cancer incidence: a population-based prospective cohort study. Br J Cancer (2012) 1.03
Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). Arthritis Res (2001) 1.01
High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease. Rheumatology (Oxford) (2008) 1.00
Changes in paraurethral connective tissue at menopause are counteracted by estrogen. Maturitas (1996) 0.99
Exposure to cadmium and persistent organochlorine pollutants and its association with bone mineral density and markers of bone metabolism on postmenopausal women. Environ Res (2009) 0.95
Daily activities and hand function in women with scleroderma. Scand J Rheumatol (2004) 0.94
25-hydroxyvitamin D accumulation during summer in elderly women at latitude 60 degrees N. J Intern Med (2009) 0.94
Disease severity of 100 patients with systemic sclerosis over a period of 14 years: using a modified Medsger scale. Ann Rheum Dis (2001) 0.93
Dietary cadmium exposure and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Br J Cancer (2011) 0.93
Mercury exposure from dental fillings. I. Mercury concentrations in blood and urine. Swed Dent J (1988) 0.91
Longitudinal development of skin involvement and reliability of high frequency ultrasound in systemic sclerosis. Ann Rheum Dis (2004) 0.91
Ultrasound examination of skin thickness in patients with progressive systemic sclerosis (scleroderma). Acta Radiol Diagn (Stockh) (1986) 0.90
Paraurethral connective tissue in stress-incontinent women after menopause. Acta Obstet Gynecol Scand (1998) 0.90
Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol (1998) 0.90
Cadmium inhibits proteoglycan and procollagen production by cultured human lung fibroblasts. Am J Respir Cell Mol Biol (1998) 0.89
Different organization of collagen fibrils in stress-incontinent women of fertile age. Acta Obstet Gynecol Scand (1998) 0.88
Labour induces increased concentrations of biglycan and hyaluronan in human fetal membranes. Placenta (2006) 0.88
Treatment of systemic sclerosis in 1988. Semin Arthritis Rheum (1989) 0.88
Working ability in relation to disease severity, everyday occupations and well-being in women with limited systemic sclerosis. Rheumatology (Oxford) (2008) 0.87
Differences in the uptake and nuclear localization of anti-proliferative heparan sulfate between human lung fibroblasts and human lung carcinoma cells. J Cell Biochem (2001) 0.87
Mecillinam and ampicillin separately or combined in gram-negative septicemia. Infection (1980) 0.87
Validation with biological markers for food intake of a dietary assessment method used by Swedish women with three different dietary preferences. Public Health Nutr (1998) 0.87
Comparison of high frequency (20 MHz) ultrasound and palpation for the assessment of skin involvement in systemic sclerosis (scleroderma). Clin Exp Rheumatol (1997) 0.86
Cytokine regulation of proteoglycan production in fibroblasts: separate and synergistic effects. Matrix Biol (1997) 0.86
A survey of Q-fever in Sweden. Eur J Epidemiol (1993) 0.86
Survival in patients with pulmonary arterial hypertension associated with systemic sclerosis from a Swedish single centre: prognosis still poor and prediction difficult. Scand J Rheumatol (2010) 0.86
Enlarged right-sided dimensions and fibrosis of the right ventricular insertion point on cardiovascular magnetic resonance imaging is seen early in patients with pulmonary arterial hypertension associated with connective tissue disease. Scand J Rheumatol (2010) 0.86
Functional bowel symptoms and GnRH antibodies: common findings in patients with primary Sjögren's syndrome but not in systemic sclerosis. Scand J Rheumatol (2009) 0.86
Normal pituitary hormone response to thyrotrophin releasing hormone in dental personnel exposed to mercury. Swed Dent J (1990) 0.86
Inhibition of in vivo leucocyte migration by NSAIDs. Clin Exp Rheumatol (1985) 0.85
Inverse relation between plasma concentration of von Willebrand factor and CrEDTA clearance in systemic sclerosis. J Rheumatol (1994) 0.85
Dietary intake and nutritional status in patients with systemic sclerosis. Ann Rheum Dis (1992) 0.84
Increased alveolar nitric oxide in early systemic sclerosis. Clin Exp Rheumatol (2010) 0.84
Interferon-alpha and ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis (2000) 0.84
BALF-derived fibroblasts differ from biopsy-derived fibroblasts in systemic sclerosis. Eur Respir J (2006) 0.84
Computer based quantitative analysis of capillary abnormalities in systemic sclerosis and its relation to plasma concentration of von Willebrand factor. Ann Rheum Dis (1996) 0.83
Distribution of selenium and glutathione peroxidase in plasma compared in healthy subjects and rheumatoid arthritis patients. Scand J Clin Lab Invest (1988) 0.83
Cardiac involvement in systemic sclerosis. Semin Arthritis Rheum (1989) 0.83
Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis. J Intern Med (2011) 0.83
Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus. Med Microbiol Immunol (1987) 0.83
Serum levels of aminoterminal type III procollagen peptide and hyaluronan predict mortality in systemic sclerosis. Scand J Rheumatol (1992) 0.83
Reduced in vivo leucocyte migration and elastase and lysozyme concentrations in skin chamber experiments with piroxicam in healthy volunteers. Clin Exp Rheumatol (1986) 0.82
Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor. Scand J Rheumatol (2011) 0.82
Two heifers with gonadal dysgenesis and the sex chromosomal constitution XY. Acta Vet Scand (1967) 0.81
Heparan/chondroitin/dermatan sulfate primer 2-(6-hydroxynaphthyl)-O-beta-D-xylopyranoside preferentially inhibits growth of transformed cells. Cancer Res (1998) 0.80
Heparan sulfate upregulates platelet-derived growth factor receptors on human lung fibroblasts. Glycobiology (1998) 0.80
Capillary density in patients with systemic sclerosis, as determined by microscopy counts and compared with computer-based analysis. Clin Exp Rheumatol (1999) 0.80
A proteomic approach to mimic fibrosis disease evolvement by an in vitro cell line. Electrophoresis (2001) 0.80
Screening for pulmonary hypertension in systemic sclerosis: the longitudinal development of tricuspid gradient in 227 consecutive patients, 1992-2001. Rheumatology (Oxford) (2004) 0.80
A skin chamber technique for leukocyte migration studies; description and reproducibility. Acta Pathol Microbiol Immunol Scand C (1985) 0.80
Decreased capillary density in juvenile dermatomyositis and in mixed connective tissue disease. J Rheumatol (1999) 0.78
Cineradiography identifies esophageal candidiasis in progressive systemic sclerosis. Clin Exp Rheumatol (1989) 0.78
Embryonic death in pigs caused by unbalanced karyotype. Acta Vet Scand (1972) 0.78
Gastrointestinal function in patients with progressive systemic sclerosis. Clin Rheumatol (1985) 0.78
Nutritional status in girls with juvenile chronic arthritis. Hum Nutr Clin Nutr (1986) 0.78
Functional properties of polymorphonuclear leukocytes accumulated in a skin chamber. Acta Pathol Microbiol Immunol Scand C (1985) 0.78
Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis. Scand J Rheumatol (1987) 0.78
Altered dermatan sulfate proteoglycan synthesis in fibroblast cultures established from skin of patients with systemic sclerosis. J Rheumatol (1996) 0.78
Mercury exposure from dental fillings. II. Release and absorption. Swed Dent J (1988) 0.78
Esophageal scintigraphy of systemic sclerosis. J Nucl Med (1995) 0.77
A qualitative and quantitative method for in situ characterization of the inflammatory response in experimental myocarditis. APMIS (1990) 0.77
Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study. Int Angiol (1988) 0.77
Relapse of skin thickening after discontinuation or decrease of azathioprine therapy in a patient with diffuse cutaneous systemic sclerosis. Rheumatology (Oxford) (2007) 0.76
Prognosis in juvenile rheumatoid arthritis with systemic onset. A follow-up study. Scand J Rheumatol (1983) 0.76
Experience with a skin chamber technique for leucocyte migration studies. Immunol Lett (1985) 0.76
Progressive capillary loss over a decade in patients with systemic sclerosis, in particular in patients with early digital ischaemic manifestations. Scand J Rheumatol (2011) 0.76
Increased serum type I interferon activity in early systemic sclerosis patients is associated with antibodies against Sjögren's syndrome antigens and nuclear ribonucleoprotein antigens. Scand J Rheumatol (2013) 0.76